Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-038724
Filing Date
2014-06-03
Accepted
2014-06-03 16:45:53
Documents
1
Period of Report
2014-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3336
  Complete submission text file 0001209191-14-038724.txt   4653
Mailing Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101
Business Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101 206-219-7815
DENDREON CORP (Issuer) CIK: 0001107332 (see all company filings)

EIN.: 223203193 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1301 2ND AVENUE SEATTLE WA 98101
Business Address
Rocco Lindsay (Reporting) CIK: 0001562381 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35546 | Film No.: 14888107